A new Pfizer initiative aims sell the pharmaceutical company’s patent-protected medicines and vaccines on a non-profit basis to 45 low-income nations. Rwanda, Ghana, Malawi, Senegal and Uganda are the first five countries to kick off the initiative, which the company says will help guide the roll out for the remaining forty countries. For more, Africa 54 health correspondent Linord Moudou spoke with Angela Hwang, group president of Pfizer Biopharmaceuticals.